Business

Neurizon Initiates Dosing in HEALEY ALS Platform Trial

Neurizon Initiates Dosing in HEALEY ALS Platform Trial

Neurizon Therapeutics LimitedFebruary 25, 20265
Neurizon Initiates Dosing in HEALEY ALS Platform Trial

About this update from Neurizon Therapeutics Limited

Neurizon Therapeutics Limited has released a press release. View Attachment

View stock analysis, news, and events for Neurizon Therapeutics Limited

More from Neurizon Therapeutics Limited

All Neurizon Therapeutics Limited news →